No Confirmed Case of Ebola in Kenya - Health Ministry Says, Calls for Vigilance

Author: kenyans.co.kePublished on: May 16, 2026Country: Kenya

Health

The Kenyan Ministry of Health stated that no cases of Ebola have been recorded in the country, despite a confirmed outbreak in the Democratic Republic of Congo (DRC) with 246 suspected cases and 65 deaths. Kenyan authorities urged the public to remain vigilant, maintain proper hygiene, and avoid contact with bodily fluids of sick individuals. The government has also activated enhanced response measures, including the formation of a National Ebola Preparedness Team.

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Ebola outbreak in Ituri: response launched in Bunia, Rwampara, and Mongwalu

HealthDemocratic Republic of the Congo

radiookapi.net•26m ago

Ebola outbreak in Ituri: response launched in Bunia, Rwampara, and Mongwalu

Several suspected cases of Ebola are being managed in Bunia and Mongwalu, where medical teams are working to identify contact persons. At the Bunia General Reference Hospital, six cases are under surveillance, while challenges persist due to a lack of resources. In Mongwalu, although barrier measures are being implemented, daily life continues almost normally, raising concerns among the population.

Charity calls for more meningitis vaccines after teenager's death

HealthUnited Kingdom

bbc.com•2h ago

Charity calls for more meningitis vaccines after teenager's death

Lewis Waters, a sixth-form pupil at The Henley College, died earlier this week after contracting meningitis. Two other pupils from Reading Blue Coat School and Highdown Secondary School are also being treated for meningitis. The charity Meningitis Now is calling for a wider rollout of the MenB vaccination for teenagers and young adults, which is currently not available in the NHS routine immunisation schedule.

The drug Tavneos causes several deaths, Japan issues alert

HealthJapan

senenews.com•2h ago

The drug Tavneos causes several deaths, Japan issues alert

The drug Tavneos, prescribed for rare autoimmune diseases, is at the center of controversy in Japan following the deaths of 20 patients since its launch in June 2022. Kissei Pharmaceutical warned doctors to stop prescribing this treatment to new patients due to the risks of severe liver dysfunction. Approximately 8,500 patients have received the drug in Japan, while no deaths related to this treatment have been reported in the United States.

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox

Learn more